You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 41 No. 7, July 1984 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (24)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Plasmapheresis With Immunosuppressive Drug Therapy in Progressive Multiple Sclerosis

A Pilot Study

Bhupendra O. Khatri, MBBS; Susan M. Koethe, PhD; Michael P. McQuillen, MD

Arch Neurol. 1984;41(7):734-738.


Abstract



• In light of encouraging preliminary data, 45 patients with severely progressive multiple sclerosis underwent long-term plasmapheresis in conjunction with low-dose cyclophosphamide and prednisone therapy. The disease progression was monitored by the Kurtzke disability status scale (DSS) and functional systems scale, neuro-ophthalmologic evaluations, evoked potentials, computed tomographic scans, and suppressor cell function assays. The conditions of 28 of the 45 patients improved significantly, the conditions of 14 patients showed limited improvement, and the conditions of three patients neither improved nor worsened. Improvement in other parameters correlated with the clinical results. Significant improvement in suppressor cell function was noted in those patients whose conditions had improved by one or more steps on the DSS.



Author Affiliations



From the Departments of Neurology (Drs Khatri and McQuillen) and Pathology (Dr Koethe), Medical College of Wisconsin, Froedtert Memorial Lutheran Hospital, Milwaukee.


Footnotes



Accepted for publication Dec 15, 1983.

Reprint requests to Department of Neurology, Medical College of Wisconsin, Froedtert Memorial Lutheran Hospital, 9200 W Wisconsin Ave, Milwaukee, WI 53226 (Dr Khatri).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Plasmapheresis in a Pregnant Patient With Multiple Sclerosis
Khatri et al.
Arch Neurol 1990;47:11-12.
ABSTRACT  

Cyclophosphamide in Chronic Progressive Multiple Sclerosis: Maintenance vs Nonmaintenance Therapy
Goodkin et al.
Arch Neurol 1987;44:823-827.
ABSTRACT  

Correlation of Clinical and Immunologic States in Multiple Sclerosis
Mickey et al.
Arch Neurol 1987;44:371-375.
ABSTRACT  

Treatment of Multiple Sclerosis
Scheinberg
Arch Neurol 1985;42:310-310.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.